Haoxi Health Technology Ltd
Room 801, Tower C, Floor 8
Building 103, Huizhongli
Chaoyang District, Beijing
Via EDGAR
Division of Corporation Finance
Office of Trade & Services
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, D.C., 20549
| Attention: | Nicholas Nalbantian |
June 11, 2025
| Re: | Haoxi Health Technology Ltd |
| Registration Statement on Form F-3, as amended | |
| Originally Filed May 30, 2025 | |
| File No. 333-287686 |
Dear Mr. Nalbantian:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Haoxi Health Technology Ltd hereby requests acceleration of effectiveness of the above referenced Registration Statement, so that it will become effective at 4:00 p.m. ET on June 13, 2025, or as soon as thereafter practicable.
Very truly yours,
| Haoxi Health Technology Ltd | |||
| By: | /s/ Zhen Fan | ||
| Name: | Zhen Fan | ||
| Title: | Chief Executive Officer | ||
| cc: | Joan Wu, Esq. |
| Hunter Taubman Fischer & Li LLC |